| scholarly article | Q13442814 |
| P50 | author | Emily Chew | Q24266614 |
| Age-Related Eye Disease Study Research Group | Q83234373 | ||
| Susan B Bressler | Q114739669 | ||
| P2093 | author name string | Traci E Clemons | |
| Wendy McBee | |||
| P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 | Q24546140 | ||
| Vision rehabilitation for age-related macular degeneration | Q33858062 | ||
| Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma | Q34211502 | ||
| The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. | Q34655539 | ||
| Measuring disease-specific quality of life in clinical trials | Q34727816 | ||
| The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. | Q36076822 | ||
| Influence of age-related maculopathy on visual functioning and health-related quality of life | Q41689744 | ||
| Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators | Q42686675 | ||
| The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. | Q43796210 | ||
| Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. | Q45983717 | ||
| The psychosocial impact of macular degeneration. | Q45994687 | ||
| Visual functioning and general health status in patients with uveitis. | Q51966015 | ||
| The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. | Q51966713 | ||
| Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. | Q51996300 | ||
| Assessment of older people: self-maintaining and instrumental activities of daily living | Q66829682 | ||
| The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial | Q73640346 | ||
| Quality of life of low-vision patients and the impact of low-vision services | Q78245039 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | questionnaire | Q747810 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 211-217 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10 | |
| P478 | volume | 121 |
| Q55470390 | A Discussion of Commercially Available Intra-ocular Telescopic Implants for Patients with Age-Related Macular Degeneration. |
| Q24186157 | Aflibercept for neovascular age-related macular degeneration |
| Q24193255 | Aflibercept for neovascular age-related macular degeneration |
| Q51037568 | An alternative way to think about glaucoma screening, using a questionnaire as a tool, Chinese version. |
| Q24201127 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24242944 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q45288386 | Anxiety, depression, and quality of life in Turkish patients with glaucoma |
| Q45850677 | Assessment of vision-related quality of life among patients with cataracts and the outcomes of cataract surgery using a newly developed visual function questionnaire: the VFQ-J11. |
| Q50473458 | Assessment of vision-related quality of life in an older population subsample: The Blue Mountains Eye Study. |
| Q37397066 | Changing Clinical Presentation, Current Knowledge-Attitude-Practice, and Current Vision Related Quality of Life in Self-Reported Type 2 Diabetes Patients with Retinopathy in Eastern India: The LVPEI Eye and Diabetes Study |
| Q90284035 | Comparison of vision-related quality of life and mental health between congenital and acquired low-vision patients |
| Q47626169 | Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration |
| Q34692207 | Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-angle glaucoma |
| Q33565104 | Driving and Age-Related Macular Degeneration |
| Q33878122 | Economic considerations of macular edema therapies |
| Q37953959 | Emotional well-being and adjustment to vision loss in later life: a meta-synthesis of qualitative studies. |
| Q56897067 | Empirical validation of the Windows® accessibility settings and multimodal feedback for a menu selection task for users with Diabetic Retinopathy |
| Q35222448 | Falling less in kansas: development of a fall risk reduction toolkit |
| Q35117715 | Foveal morphology affects self-perceived visual function and treatment response in neovascular age-related macular degeneration: a cohort study. |
| Q46123232 | Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). |
| Q34924529 | Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium |
| Q35059037 | Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review |
| Q34081879 | Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials Report No. 5. |
| Q37517122 | How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. |
| Q33356851 | Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial |
| Q33837372 | Patients' knowledge and perspectives on wet age-related macular degeneration and its treatment |
| Q39719946 | Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration |
| Q90536987 | Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration |
| Q24817165 | Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version |
| Q92621440 | Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population |
| Q51906113 | Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration--a report of 1 year results. |
| Q37118754 | Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools |
| Q34565430 | Quality of life in patients with Graves ophthalmopathy. |
| Q34362553 | Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease |
| Q48617600 | Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation. |
| Q37211244 | Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study |
| Q90281992 | Regional differences in vision health: findings from Mwanza, Tanzania |
| Q37304476 | Regional replication of association with refractive error on 15q14 and 15q25 in the Age-Related Eye Disease Study cohort |
| Q34328499 | Resource utilization and costs of age-related macular degeneration. |
| Q34655503 | Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14 |
| Q46777540 | SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion |
| Q36797862 | Single-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice |
| Q42374496 | Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs |
| Q89454097 | Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes |
| Q34472219 | Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy |
| Q34492469 | The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project |
| Q43672537 | The economic costs and benefits of dog guides for the blind |
| Q37297814 | The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration |
| Q36393004 | Using the real-life vision test to assess the functional vision of age-related cataract patients |
| Q36116529 | Validity and reliability of the Children's Visual Function Questionnaire (CVFQ) |
| Q48852603 | Validity and reliability study for the NEI-VFO-39 scale in chronic ophthalmic diseases--Turkish version. |
| Q42992035 | Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration |
| Q46716950 | Whole-exome sequencing implicates UBE3D in age-related macular degeneration in East Asian populations |
| Q34820020 | Why is tractable vision loss in older people being missed? Qualitative study |
| Q80118546 | [Quality of life in patients with wet age-related macular degeneration treated with photodynamic therapy] |
| Q36529587 | r2VIM: A new variable selection method for random forests in genome-wide association studies |
Search more.